Novo Nordisk CEO steps down as Wegovy maker faces increased competition
Novo Nordisk CEO Lars Fruergaard Jorgensen is stepping down as competition in the weight-loss drug space pressured the company’s stock. “Considering the recent market challenges, the share price decline, and…

